[Hypotensive effect of saluretics].
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000031:analogs & derivatives; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008750:Methyldopa / Q000008:administration & dosage; D008875:Middle Aged; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage; D013997:Time Factors
D000959:Antihypertensive Agents; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D008750:Methyldopa; C009732:buthiazide
L'effetto ipotensivo dei saluretici.